Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
96 Leser
Artikel bewerten:
(0)

Global Medical Shoes Market 2017-2022: Significant Growth with a CAGR of 8.12 % - Research and Markets

DUBLIN, June 2, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Medical Shoes Market: Analysis By Product Type, By End User, By Distribution Channel, By Region, By Country: Opportunities and Forecast (2017-2022) - By Product Type, By End User, By distribution Channel, By Region, By Country" report to their offering.

Research and Markets Logo

The global market is projected to display a significant growth represented by a CAGR of 8.12 % during 2017-2022, chiefly driven by increasing number of patients with diabetes, rising geriatric population, growing awareness about foot health and increasing healthcare expenditure. The Medical Shoes market is developing at slower pace majorly due to lack of awareness about foot health and high preference for fashionable shoes.

Orthopedic Shoes are gaining significant importance as the next major development in Medical Shoes; however, there are certain challenges that will need to be addressed, including complex technology design, law awareness about foot health, No insurance coverage on Medical Shoes in many emerging markets, high cost of shoes, delivery methods and identifying the most appropriate patient population to benefit from these type of shoes. Further, advent of new diabetic shoes is going to boost the global market in the forecast period.

In the recent years, there are many players coming up with proven positive results of diabetic shoes. The players are aggressively launching new products with enhanced functionality, better gait movement and fashionable designs. Diabetic shoes have been a major focus in Medical Shoes Industry as these shoes can reduce the risk of foot problems among diabetes patients as they are more vulnerable to severe foot diseases and low limb amputation.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Medical Shoes Market Outlook

5. Global Medical Shoes Market: Growth and Forecast

6. Global Medical Shoes Market: Analysis By Product Type

7. North America Medical Shoes Market: Growth and Forecast

8. North America Medical Shoes Market: An Analysis

9. Europe Medical Shoes Market: Growth and Forecast

10. Europe Medical Shoes Market- Analysis By Product Type

11. Asia-Pacific Medical Shoes Market: Growth and Forecast

12. Asia-Pacific Medical Shoes Market: An Analysis

13. ROW Medical Shoes Market: Growth and Forecast

14. ROW Medical Shoes Market: An Analysis

15. Market Dynamics

16. Market Trends

17. Porter's Five Forces Analysis - Heart Valve Devices Market

18. SWOT Analysis -Heart Valve Devices Market

19. Supply Chain Analysis

20. Competitive Landscape

21. Company Profiles

  • Aetrex Worldwide, Inc.
  • Apex Foot Health Industries
  • DARCO International, Inc.
  • Dr. Comfort
  • Dr. Zen, Inc.
  • Drew Shoe Corporation
  • Dune srl
  • Francis Lavigne Development
  • OrthoFeet
  • Podartis srl

For more information about this report visit http://www.researchandmarkets.com/research/46xmxt/global_medical

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.